Patent ID: 8466134

Claim:
A composition suitable for administering a therapeutic dose of a corticosteroid which is budesonide, to the respiratory tract, consisting of: (a) from about 5 μg/ml to about 5 mg/ml of the corticosteroid in dissolved form; (b) from about 0.1 to about 20 percent by weight of a pharmaceutically acceptable, high-HLB surfactant component, wherein the HLB of the surfactants present in the high-HLB surfactant component is greater than about 10, and wherein the high-HLB surfactant component comprises at least 50% by weight of an ethoxylated derivative of vitamin E, wherein said ethoxylated derivative of vitamin E is the sole vitamin E component of the composition; and (c) at least about 70 weight percent aqueous phase.